Review Note
Last Update: 10/17/2023 09:37 PM
Current Deck: All Exams P1::IE #5 115-L01
PublishedCurrently Published Content
Text
Fibric Acid Derivatives
- {{c1::Dose adjust in renal impairment}}
- Contraindications
- {{c1::Dose adjust in renal impairment}}
- Contraindications
• {{c2::Hepatic impairment}}
• {{c3::Severe renal impairment}}
• {{c3::Gallbladder Disease}}
• {{c4::Concurrent Statin use (increased risk of myopathy)}}
• {{c4::Gemfibrozil contraindicated with Repaglinide (increased hypoglycemia)}}
• {{c3::Severe renal impairment}}
• {{c3::Gallbladder Disease}}
• {{c4::Concurrent Statin use (increased risk of myopathy)}}
• {{c4::Gemfibrozil contraindicated with Repaglinide (increased hypoglycemia)}}
Back Extra
No published tags.
Pending Suggestions
No pending suggestions for this note.